neo's pcta guide wire non hydrophilic coating - catheter guide wire
bio-excel australia pty ltd - 35094 - catheter guide wire - stainless steel steerable wire with radio-opaque coil and polymer coatings positioning and moving a catheter through a blood vessel
neo's pcta guidewire hydrophilic coating - catheter guide wire
bio-excel australia pty ltd - 35094 - catheter guide wire - stainless steel steerable wire with radio-opaque coil and polymer coatings positioning and moving a catheter through a blood vessel
asahi zenyteex ptca guiding catheter - catheter, intravascular, guiding
bio-excel australia pty ltd -
stride microcatheter - catheter, infusion
bio-excel australia pty ltd -
precipitated calcium carbonate tablets 500mg "asahi kasei" (炭カル錠500mg「旭化成」)
asahi kasei pharma corporation - precipitated calcium carbonate - white tablet, diameter: 9.5 mm, thickness: 5.1 mm
prednisolone tablets 1mg "asahi kasei" (プレドニゾロン錠1mg(旭化成))
asahi kasei pharma corporation - prednisolone - white tablet, diameter: 6.5 mm, thickness: 2.7 mm
prednisolone tablets 5mg "asahi kasei" (プレドニゾロン錠5mg(旭化成))
asahi kasei pharma corporation - prednisolone - white tablet, diameter: 7.7 mm, thickness: 2.5 mm
teriparatide acetate inj.100 "asahi kasei" (テリパラチド酢酸塩静注用100「旭化成」)
asahi kasei pharma corporation - teriparatide acetate - injection
tranexamic acid capsules 250mg "asahi kasei" (トラネキサム酸カプセル250mg「旭化成」)
asahi kasei pharma corporation - tranexamic acid - orange and pale yellow capsule,whole length:17.6mm
mycamine micafungin (as sodium) 100 mg powder for injection vial
astellas pharma australia pty ltd - micafungin sodium, quantity: 101.73 mg (equivalent: micafungin, qty 100 mg) - injection, powder for - excipient ingredients: citric acid; sodium hydroxide; lactose monohydrate - mycamine is indicated for: ? treatment of invasive candidiasis in children and adults ? treatment of oesophageal candidiasis in adults, adolescents greater than or equal to 16 years of age and the elderly patients for whom intravenous therapy is appropriate ? prophylaxis of candida infection in children and adult patients undergoing allogeneic haematopoietic stem cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count < 500 cells/?l) for 10 or more days.